Conmed CORP Schedule 13G passive stakes

Vanguard Capital Management has reported beneficial ownership of 5.25% of CONMED Corp's common stock as of March 31, 2026.

Vanguard Portfolio Management has reported a beneficial ownership of 6.87% in CONMED Corp's common stock as of March 31, 2026.

The Vanguard Group has reported zero beneficial ownership in CONMED Corp following an internal realignment, with subsidiaries now reporting holdings separately.

Capital Research Global Investors has filed an Amendment No. 3 to its Schedule 13G, disclosing a 3.3% beneficial ownership in CONMED Corp. common stock.

Fuller & Thaler Asset Management, Inc. has disclosed a 5.63% beneficial ownership stake in Conmed Corp, totaling 1,740,630.07 common shares.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 15.1% beneficial ownership stake in CONMED Corp's common stock as of June 30, 2025.